Results 1 to 10 of about 415,627 (236)
Matrix metalloproteinase‐9: A magic drug target in neuropsychiatry? [PDF]
Journal of Neurochemistry, 2023 Neuropsychiatric conditions represent a major medical and societal challenge. The etiology of these conditions is very complex and combines genetic and environmental factors. The latter, for example, excessive maternal or early postnatal inflammation, as
Krzysztof T. Kaczmarek +2 more
openalex +2 more sources
Training in neuropsychiatry: views of early career psychiatrists from across the world
BJPsych Bulletin, 2023 Background Training and practice in neuropsychiatry varies across the world. However, little is known about the experiences and opinions of early career psychiatrists (ECPs) across different countries regarding neuropsychiatry.
Rosa Molina-Ruiz +18 more
doaj +2 more sources
Neuroimaging-Based Brain Age Estimation: A Promising Personalized Biomarker in Neuropsychiatry [PDF]
Journal of Personalized Medicine, 2022 It is now possible to estimate an individual’s brain age via brain scans and machine-learning models. This validated technique has opened up new avenues for addressing clinical questions in neurology, and, in this review, we summarize the many clinical ...
Daichi Sone, Iman Beheshti
openalex +2 more sources
Editorial of Special Issue “Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry” [PDF]
Biomedicines, 2021 "Where there is light, there must be shadow, [...].
Masaru Tanaka, László Vécsei
openalex +2 more sources
Brain age and other bodily ‘ages’: implications for neuropsychiatry [PDF]
Molecular Psychiatry, 2018 As our brains age, we tend to experience cognitive decline and are at greater risk of neurodegenerative disease and dementia. Symptoms of chronic neuropsychiatric diseases are also exacerbated during ageing.
James H. Cole +3 more
openalex +2 more sources
New directions in neurosteroid therapeutics in neuropsychiatry
Neuroscience and Biobehavioral ReviewsCharles F. Zorumski +5 more
openalex +2 more sources
Journal of Neurology Neurosurgery & Psychiatry, 2021 There is accumulating evidence of the neurological and neuropsychiatric features of infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to describe the characteristics of the early literature and estimate point prevalences ...
Jonathan P. Rogers +29 more
semanticscholar +1 more source
Frontiers in Human Neuroscience, 2022 We describe our clinical experience in treating patients with Tourette syndrome and other tic disorders using infra-low frequency neurofeedback (ILF NF), often in conjunction with cognitive behavior therapy.
Bodil Solberg, Erlend Solberg
doaj +1 more source
Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy
CNS Spectrums, 2022 Psilocybin is a tryptamine alkaloid found in some mushrooms, especially those of the genus Psilocybe. Psilocybin has four metabolites including the pharmacologically active primary metabolite psilocin, which readily enters the systemic circulation.
S. Dodd +6 more
semanticscholar +1 more source
Biomedicines, 2022 "To learning much inclined, who went to see the Elephant (though all of them were blind) that each by observation might satisfy the mind" [...].
Masaru Tanaka +2 more
semanticscholar +1 more source